WebGet the latest Marker Therapeutics Inc (MRKR) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Web5 days ago · Topline readout of Phase 2 AML trial Group 2 active disease anticipated in Q2 2022. Get a real-time Marker Therapeutics, Inc. (MRKR) stock price quote with breaking news, financials, statistics, charts and more.
DA:80PA:16MOZ Rank:58
Marker Therapeutics, Inc. (MRKR) Stock Price, Quote, News
WebA high-level overview of Marker Therapeutics, Inc. (MRKR) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.